Ashwath Jayagopal

Company: Opus Genetics

Job title: Chief Scientific Officer

Seminars:

Evolution of Gene Therapy for Ocular Diseases as Long-Acting Treatment 1:30 pm

Gene therapies provide a lot of promise as long-acting treatment for ophthalmic diseases. Providing the retinal cells with the genetic information to reproduce the drug within the eye, gene therapies create a bio-factory, meaning that the drugs can last many years with a single injection. However, the field is still evolving and requires its bolts…Read more

day: Pre-Conference Workshop Day - WORKSHOP F